Tak Cheung is a Partner at New Enterprise Associates (NEA), a venture capital firm founded in 1977. See sector focus and contact routes.
Tak Cheung is a Partner at New Enterprise Associates (NEA), a venture capital firm founded in 1977, with a background in medical devices and experience in commercialization, product launch, and acquisition integration. His investment focus centers on healthcare, leveraging his prior roles as Vice President of Business Development at Bausch + Lomb and Director at Edwards Lifesciences, as well as co-founding Lexington Medical, Inc.. NEA invests across all growth stages from pre-seed to IPO in technology and healthcare sectors, including life sciences and digital health, with a global footprint spanning the U.S., India, and China. While specific check sizes and lead/follow behavior for Cheung are not publicly detailed, NEA’s thesis emphasizes partnering with founders at every stage and providing operational support beyond capital. Cheung serves on the boards of Allay Therapeutics, SpyGlass Ophthalmics, Foundry SING1, Magenta Medical, and Vesper Medical, reflecting active involvement in ophthalmology and medical device companies. No distinctive public writing or unique point of view from Cheung himself is documented in available sources, though his board roles h
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Menlo Park.
Investors like Tak Cheung · Full investor directory · Investor access · Company funding database